Advancing polymeric delivery systems amidst a nucleic acid therapy renaissance

Paul A. Burke, Suzie H. Pun, Theresa M. Reineke

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Nucleic acid therapeutics are attracting renewed interest due to recent clinical advances and product approvals. Most leading programs use chemical conjugates, or viral vectors in the case of gene therapy, while several use no delivery system at all. Polymer systems, which have been at the periphery of this renaissance, often involve greater molecular complexity than competing approaches, which must be justified by their advantages. Advanced analytical methods, along with biological tools for characterizing biotransformation and intracellular trafficking, are increasingly being applied to nucleic acid delivery systems including those based on polymers. These frontiers of investigation create the opportunity for an era where highly defined polymer compositions are optimized based on mechanistic insights in a way that has not been previously possible, offering the prospect of greater differentiation from alternatives. This will require integrated collaboration between polymer scientists and those from other disciplines.

Original languageEnglish (US)
Pages (from-to)928-934
Number of pages7
JournalACS Macro Letters
Volume2
Issue number10
DOIs
StatePublished - Oct 28 2013

Fingerprint Dive into the research topics of 'Advancing polymeric delivery systems amidst a nucleic acid therapy renaissance'. Together they form a unique fingerprint.

Cite this